Safety and efficacy of SGLT2 inhibitors in heart failure patients with ischemic and non-ischemic etiologies: a systematic review and meta-analyses

Safety and efficacy of SGLT2 inhibitors in heart failure patients with ischemic and non-ischemic etiologies: a systematic review and meta-analyses

Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT2is) show promise as a therapy for heart failure (HF); however, the safety and efficacy of SGLT2i in different HF etiologies are uncertain, thus arising the need for a meta-analyses. Main text PubMed and Scopus were queried until May...

Full description

Saved in:
Bibliographic Details
Main Authors: Hasan Fareed Siddiqui, Adam Bilal Khan, Muhammad Moiz Nasir, Taleen Hashmi, Aisha Fareed Siddiqui, Hanzla Asim, Bushra Iqtidar Siddiqui
Format: Article
Language:English
Published: SpringerOpen 2025-03-01
Series:The Egyptian Heart Journal
Subjects:
Sodium-glucose cotransporter 2 inhibitors
Heart failure
Cardiovascular death
Hospitalization due to heart failure
All-cause mortality
Meta-analyses
Online Access:https://doi.org/10.1186/s43044-025-00623-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s43044-025-00623-5

Similar Items